# Partial Support Ventilation and Mitochondrial-Targeted Antioxidants Protect against Ventilator-Induced Decreases in Diaphragm Muscle Protein Synthesis

**Authors:** Matthew B. Hudson, Ashley J. Smuder, W. Bradley Nelson, Michael P. Wiggs, Kevin L. Shimkus, James D. Fluckey, Hazel H. Szeto, Scott K. Powers

PMC · DOI: 10.1371/journal.pone.0137693 · PLoS ONE · 2015-09-11

## TL;DR

This study shows that partial ventilation or antioxidants can prevent muscle protein loss in the diaphragm caused by prolonged mechanical ventilation.

## Contribution

The study introduces partial-support ventilation and mitochondrial antioxidants as novel strategies to preserve diaphragm protein synthesis during mechanical ventilation.

## Key findings

- Partial-support MV preserved diaphragm protein synthesis at levels similar to spontaneous breathing.
- Mitochondrial-targeted antioxidants prevented oxidative stress and maintained protein synthesis during full-support MV.

## Abstract

Mechanical ventilation (MV) is a life-saving intervention in patients in respiratory failure. Unfortunately, prolonged MV results in the rapid development of diaphragm atrophy and weakness. MV-induced diaphragmatic weakness is significant because inspiratory muscle dysfunction is a risk factor for problematic weaning from MV. Therefore, developing a clinical intervention to prevent MV-induced diaphragm atrophy is important. In this regard, MV-induced diaphragmatic atrophy occurs due to both increased proteolysis and decreased protein synthesis. While efforts to impede MV-induced increased proteolysis in the diaphragm are well-documented, only one study has investigated methods of preserving diaphragmatic protein synthesis during prolonged MV. Therefore, we evaluated the efficacy of two therapeutic interventions that, conceptually, have the potential to sustain protein synthesis in the rat diaphragm during prolonged MV. Specifically, these experiments were designed to: 1) determine if partial-support MV will protect against the decrease in diaphragmatic protein synthesis that occurs during prolonged full-support MV; and 2) establish if treatment with a mitochondrial-targeted antioxidant will maintain diaphragm protein synthesis during full-support MV. Compared to spontaneously breathing animals, full support MV resulted in a significant decline in diaphragmatic protein synthesis during 12 hours of MV. In contrast, diaphragm protein synthesis rates were maintained during partial support MV at levels comparable to spontaneous breathing animals. Further, treatment of animals with a mitochondrial-targeted antioxidant prevented oxidative stress during full support MV and maintained diaphragm protein synthesis at the level of spontaneous breathing animals. We conclude that treatment with mitochondrial-targeted antioxidants or the use of partial-support MV are potential strategies to preserve diaphragm protein synthesis during prolonged MV.

## Linked entities

- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, AKT1S1 (AKT1 substrate 1) [NCBI Gene 84335] {aka Lobe, PRAS40}, RPS6KB1 (ribosomal protein S6 kinase B1) [NCBI Gene 6198] {aka PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70 S6KA}, TUBA1B (tubulin alpha 1b) [NCBI Gene 10376] {aka K-ALPHA-1}, RPS6 (ribosomal protein S6) [NCBI Gene 6194] {aka S6, eS6}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, Casp3 (caspase 3) [NCBI Gene 25402] {aka CPP32-beta, Lice, Yama}, EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1) [NCBI Gene 1978] {aka 4E-BP1, 4EBP1, BP-1, PHAS-I}, EIF4E (eukaryotic translation initiation factor 4E) [NCBI Gene 1977] {aka AUTS19, CBP, EIF4E1, EIF4EL1, EIF4F, eIF-4E}, ELANE (elastase, neutrophil expressed) [NCBI Gene 1991] {aka ELA2, GE, HLE, HNE, NE, PMN-E}
- **Diseases:** lung damage (MESH:D008171), VIDD (MESH:D055397), visual abnormalities (MESH:D014786), respiratory failure (MESH:D012131), infection (MESH:D007239), impaired respiratory muscle function (MESH:D009135), spinal cord injury (MESH:D013119), diaphragm muscle atrophy (MESH:D009133), depressed (MESH:D003866), diaphragm atrophy (MESH:D001284), disuse muscle atrophy (MESH:D020966), diaphragm weakness (MESH:D018908), CMV (MESH:D053717), diaphragmatic atrophy (MESH:C536880), drug overdose (MESH:D062787), diaphragm (MESH:D065630), critically ill (MESH:D016638),  (MESH:D004195)
- **Chemicals:** CO2 (MESH:D002245), ethanol (MESH:D000431), acetonitrile (MESH:C032159), ammonium hydroxide (MESH:D064753), aldehydes (MESH:D000447), Lipid (MESH:D008055), HCL (MESH:D006851), phenylalanine (MESH:D010649), amino acid (MESH:D000596), sulfosalicylic acid (MESH:C003366), 4 hydroxynonenal (MESH:C027576), sodium pentobarbital (MESH:D010424), TCA (MESH:D014238), H2O (MESH:D014867), CMVSS (-),  (MESH:D000975)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4567376/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4567376/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC4567376/full.md

---
Source: https://tomesphere.com/paper/PMC4567376